Media & Resources

Adding a vaccine to the comprehensive HIV/AIDS response is essential to conclusively ending the epidemic, according to modeling research published today.

IAVI researchers contributed to two recent papers that outline progress toward designing a vaccine to induce broadly neutralizing antibodies (bNAbs) against HIV. 

NEW YORK — Expert leaders from five diverse local, national and international organizations underscored the urgent need to work together to end AIDS, during a lively panel discussion Tuesday evening. The panelists represented a broad cross-section from the frontlines of the battle against HIV/AIDS: Mary T. Bassett, Commissioner of the New York City Department of…

Tomorrow, people around the world will pause to mark the 27th annual World AIDS Day with a renewed commitment to ending the epidemic. In New York City, five diverse leaders of the fight against AIDS will gather to hold an engaging conversation about what it will take to defeat HIV/AIDS in our lifetimes. HIV has…

Identifying essential factors for both researchers and CBOs to consider in the design, conduct, implementation, validation, and dissemination of studies in order to protect the rights and safety of study participants.

The International AIDS Vaccine Initiative (IAVI) is pleased to announce that Francine Ntoumi, Founder, Chair and Executive Director of the Congolese Foundation for Medical Research, has joined its Board of Directors. “We are very pleased to welcome Dr. Ntoumi to IAVI’s Board,” said IAVI Board Chair Alex Coutinho. “Her pioneering work in infection research and…

NEW YORK – The International AIDS Vaccine Initiative (IAVI) will provide product development expertise and laboratory assessment support to a new research consortium announced today called the European AIDS Vaccine Initiative (EAVI2020). Funded by a European Union grant under the Horizon 2020 health program, the consortium unites 22 public organizations and biotech companies across Europe,…

MedImmune is the newest member of the Human Vaccines Project, which will help to accelerate the research and development of vaccines and immunotherapies for infectious disease and cancer.